Petros Pharmaceuticals, Inc.
PTPI
$0.0196
-$0.0383-66.15%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -14.32M | -4.73M | -7.06M | -8.94M | -8.16M |
| Total Depreciation and Amortization | 2.94M | 3.11M | 3.21M | 3.31M | 3.42M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.25M | -8.26M | -6.68M | -5.20M | -3.50M |
| Change in Net Operating Assets | 4.53M | 4.04M | 1.43M | 2.82M | 624.90K |
| Cash from Operations | -2.60M | -5.83M | -9.10M | -8.01M | -7.63M |
| Capital Expenditure | -24.50K | -19.10K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -24.50K | -19.10K | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -765.30K | -1.14M | -1.12M | -1.11M | -1.46M |
| Issuance of Common Stock | -- | 0.00 | 15.00M | 15.00M | 15.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -6.23M | -7.09M | -4.70M | -3.12M | -2.00M |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -7.00M | -8.23M | 9.18M | 10.77M | 11.54M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.63M | -14.08M | 75.20K | 2.76M | 3.91M |